Laboratórios Mastellini
Laboratório Mastellini, founded in 2006, is a leading provider of clinical analysis services with a mission to deliver quality, reliable, and efficient laboratory services. The company emphasizes innovation, high standards of quality and safety, and a patient-centered approach. It has expanded across multiple cities in the Northwest Paulista region and is recognized for its excellence in diagnostics, including being the first in the region to conduct COVID testing. The company values continuous improvement, professional development, and maintaining international standards of quality and security.
Industries
Nr. of Employees
medium (51-250)
Laboratórios Mastellini
R. Osvaldo Cruz, 109, Adamantina, SP
Products
Non-invasive fetal sex determination (cfDNA)
Maternal blood-based test for fetal sex determination from early gestation using cell-free fetal DNA assays; includes specified tube type and centrifugation requirements.
COVID-19 antigen testing (nasopharyngeal swab)
Antigen-based nasal/nasopharyngeal test intended for symptomatic individuals in early phase of infection; facility scheduling required.
Paternity / DNA identity test
Blood-based paternity testing with documented identity requirements and combined sample collection procedures; typical turnaround up to 20 business days.
Urine culture with antibiogram
Microbiological culture of urine for pathogen identification and antimicrobial susceptibility testing to guide therapy.
Neonatal screening (heel-prick)
Newborn metabolic and congenital disorder screening collected at recommended postnatal windows, with protocols for repeat sampling after transfusion when indicated.
Urinalysis (simple urine / tipo 1)
Routine urine screening including chemical strip analysis and microscopic sediment exam for common urinary parameters.
Non-invasive fetal sex determination (cfDNA)
Maternal blood-based test for fetal sex determination from early gestation using cell-free fetal DNA assays; includes specified tube type and centrifugation requirements.
COVID-19 antigen testing (nasopharyngeal swab)
Antigen-based nasal/nasopharyngeal test intended for symptomatic individuals in early phase of infection; facility scheduling required.
Paternity / DNA identity test
Blood-based paternity testing with documented identity requirements and combined sample collection procedures; typical turnaround up to 20 business days.
Urine culture with antibiogram
Microbiological culture of urine for pathogen identification and antimicrobial susceptibility testing to guide therapy.
Neonatal screening (heel-prick)
Newborn metabolic and congenital disorder screening collected at recommended postnatal windows, with protocols for repeat sampling after transfusion when indicated.
Urinalysis (simple urine / tipo 1)
Routine urine screening including chemical strip analysis and microscopic sediment exam for common urinary parameters.
Services
On-site domiciliary phlebotomy and specimen pickup arranged by appointment.
Scheduled collection services at corporate sites for employee health programs and occupational testing.
Specialized scheduling and collection protocols aimed at reducing distress during pediatric blood draws.
Electronic portal for patients, clinicians and partners to access laboratory results and restricted-area access for partners and physicians.
Provision of centralized laboratory services and integration with institutional workflows to expand internal diagnostic capacity without additional infrastructure investment.
On-site domiciliary phlebotomy and specimen pickup arranged by appointment.
Scheduled collection services at corporate sites for employee health programs and occupational testing.
Specialized scheduling and collection protocols aimed at reducing distress during pediatric blood draws.
Electronic portal for patients, clinicians and partners to access laboratory results and restricted-area access for partners and physicians.
Provision of centralized laboratory services and integration with institutional workflows to expand internal diagnostic capacity without additional infrastructure investment.
Expertise Areas
- Clinical laboratory diagnostics
- Molecular diagnostics (PCR and antigen testing)
- Microbiology and antimicrobial susceptibility testing
- Urinalysis and routine urine screening
Key Technologies
- Polymerase chain reaction (PCR)
- Antigen detection assays
- Cell-free DNA analysis (cfDNA)
- DNA profiling / genetic analysis
News & Updates
Laboratório Mastellini's COVID Testing Milestone
First in the region to conduct COVID PCR and antigen tests, expanding regional diagnostic capabilities.
Expansion Across Cities
The company has expanded its services to 14 cities in the Northwest Paulista region.
New Units for Toxicological and Thyroid Testing
New regional units now offer specialized tests like T4, TSH, and toxicology, increasing accessibility.
Newborn Screening and Dengue Testing Expansion
Additional units now provide newborn screening and dengue tests, enhancing regional health services.
ISO 9001 Certification
Recognition of quality management standards, including the main unit in Presidente Prudente.
PNCQ Certification
Adherence to high standards in clinical analysis, ensuring diagnostic accuracy.
Laboratório Mastellini's COVID Testing Milestone
First in the region to conduct COVID PCR and antigen tests, expanding regional diagnostic capabilities.
Expansion Across Cities
The company has expanded its services to 14 cities in the Northwest Paulista region.
New Units for Toxicological and Thyroid Testing
New regional units now offer specialized tests like T4, TSH, and toxicology, increasing accessibility.
Newborn Screening and Dengue Testing Expansion
Additional units now provide newborn screening and dengue tests, enhancing regional health services.
ISO 9001 Certification
Recognition of quality management standards, including the main unit in Presidente Prudente.
PNCQ Certification
Adherence to high standards in clinical analysis, ensuring diagnostic accuracy.